Quadrant Capital Group LLC Cure Vac N.V. Transaction History
Quadrant Capital Group LLC
- $1.43 Billion
- Q4 2024
A detailed history of Quadrant Capital Group LLC transactions in Cure Vac N.V. stock. As of the latest transaction made, Quadrant Capital Group LLC holds 50,016 shares of CVAC stock, worth $153,549. This represents 0.01% of its overall portfolio holdings.
Number of Shares
50,016
Previous 30,918
61.77%
Holding current value
$153,549
Previous $90,000
88.89%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding CVAC
# of Institutions
86Shares Held
10.5MCall Options Held
75.5KPut Options Held
33.5K-
Black Rock Inc. New York, NY2.25MShares$6.92 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.65MShares$5.06 Million0.0% of portfolio
-
Bill & Melinda Gates Foundation Seattle, WA1.57MShares$4.82 Million10.6% of portfolio
-
Ubs Group Ag577KShares$1.77 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL500KShares$1.54 Million0.01% of portfolio
About CureVac N.V.
- Ticker CVAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,467,008
- Market Cap $576M
- Description
- CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...